Navigation Links
International Symposium on Malignant Mesothelioma 2008
Date:5/28/2008

Targeting a Cure

WASHINGTON, May 28 /PRNewswire/ -- Leading international experts on the asbestos-related cancer, mesothelioma, will join meso patients, caregivers, loved ones and advocates to share the latest in treatment, research and clinical trials at the Mesothelioma Applied Research Foundation's International Symposium on Malignant Mesothelioma, 2008, Thursday, June 26 - Saturday, June 28 at the Hyatt Regency on Capitol Hill, in Washington, D.C.

The Symposium, organized annually by the Meso Foundation, will highlight the latest advances in research and treatment for patients and caregivers, offer psychosocial support to them as well as those who have lost someone to the disease, and provide significant advocacy and volunteer opportunities for all who are intent on eradicating the vicious and terminal effects of this tragic cancer.

Day 1: Advocacy, Thursday, June 26 is a rallying cry to the House of Representatives to move quickly on legislation banning asbestos and providing research funding for meso and asbestos related diseases. This legislation must be conferenced with the companion bill in the Senate and signed into law by the President before year-end. The second advocacy objective is to request that the Senate's Defense Appropriations Subcommittee maintain, for a second year, mesothelioma's eligibility to compete for medical research funding from the Department of Defense.

The Symposium's Co-Chairs, Dr. Nicholas J. Vogelzang, Chairman of the Meso Foundation's Board of Directors and the Director of Nevada Cancer Institute, and Dr. Raffit Hassan, Chairman of the Meso Foundation's Science Advisory Board and an Investigator at the National Cancer Institute, have put together an impressive and prestigious group of panelists for Day 2: Science, Friday, June 27.

A Gala Dinner will be held Friday evening, June 27, with three awards presented to individuals in recognition of their special contributions to the cause. Seventh grader Lexi Miletto, the granddaughter of Joseph Miletto who died in 2005 of peritoneal mesothelioma, will provide a personal perspective as a featured speaker.

Day 3: Community, Saturday, June 28, will be devoted to the community of meso patients, families and caregivers.

A tribute ceremony will be held memorializing those who passed away with the unveiling of a tribute wall listing their names.

To register for the Symposium and detailed program information, visit http://www.curemeso.org.


'/>"/>
SOURCE Mesothelioma Applied Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):